First Randomized, Multicenter, Placebo-Controlled Study of Self-Administered Intranasal Etripamil for Acute Conversion of Spontaneous Paroxysmal Supraventricular Tachycardia (NODE-301)

Pharmacologic termination of paroxysmal supraventricular tachycardia (PSVT) often requires medically supervised intervention. Intranasal etripamil, is an investigational fast-acting, nondihydropyridine, L-type calcium channel blocker, designed for unsupervised self-administration to terminate atriov...

Descripción completa

Detalles Bibliográficos
Autores principales: Stambler, Bruce S., Plat, Francis, Sager, Philip T., Shardonofsky, Silvia, Wight, Douglas, Potvin, Diane, Pandey, A. Shekhar, Ip, James E., Coutu, Benoit, Mondésert, Blandine, Sterns, Laurence D., Bennett, Matthew, Anderson, Jeffrey L., Damle, Roger, Haberman, Ronald, Camm, A. John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760458/
https://www.ncbi.nlm.nih.gov/pubmed/36441560
http://dx.doi.org/10.1161/CIRCEP.122.010915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760458/
https://www.ncbi.nlm.nih.gov/pubmed/36441560
http://dx.doi.org/10.1161/CIRCEP.122.010915

Ejemplares similares